BIIB
Biogen (BIIB) Investor Questions
Review Biogen (BIIB) faq with server-rendered company data, supporting context and links to related investor research.
- Company
- Biogen
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Overall BTI score
- 64
- Annual revenue
- $9.89B
- Annual net income
- $1.29B
- Annual free cash flow
- $2.05B
Biogen (BIIB) Investor Questions research
Biogen trades under the ticker BIIB. The company is classified in the Healthcare sector and the Drug Manufacturers - General industry.
Investors commonly review BIIB through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. The linked research sections provide a separate crawlable page for each data-rich topic.